Effects of Iron Supplementation on Erythropoietic Response in Patients with Cancer-Associated Anemia Treated by Means of Erythropoietic Stimulating Agents

During the past decade, intravenous iron supplementation to ESA (erythropoiesis-stimulating agent) therapy has emerged as an option to augment hemoglobin response in anemic cancer patients. In this paper, the results of seven published randomized clinical trials assessing the role of iron supplement...

Descripción completa

Detalles Bibliográficos
Autor principal: Karlsson, Torbjörn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196863/
https://www.ncbi.nlm.nih.gov/pubmed/22111015
http://dx.doi.org/10.5402/2011/108397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196863/
https://www.ncbi.nlm.nih.gov/pubmed/22111015
http://dx.doi.org/10.5402/2011/108397

Ejemplares similares